- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05968560
Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis
January 16, 2026 updated by: Yulia Landa, Icahn School of Medicine at Mount Sinai
Telehealth Adaptation of Group and Family-Based Cognitive Behavioral Therapy for Youth at Risk for Psychosis
This study aims to evaluate the feasibility and effectiveness of telehealth interventions for individuals at clinical high risk for psychosis (CHR).
Psychosis typically emerges during late adolescence or early adulthood, significantly impacting long-term functioning.
While CHR programs have the potential to reduce illness severity, individuals often face barriers such as stigma and limited access to services.
Telehealth interventions could address these barriers and improve treatment accessibility and engagement.
The study will focus on Group and Family-Based Cognitive Behavioral Therapy, Family-Based CBT, and individual CBT, adapted for telehealth delivery (GF-CBT-TH, F-CBT-TH, and I-CBT-TH).
Participants aged 14-25 who meet CHR criteria will be randomly assigned to one of these interventions.
Feasibility will be measured by recruitment rate, attendance, and retention.
The study will assess the impact of the interventions on cognitive biases, social connectedness, family emotional climate, and proficiency in CBT skills.
The three intervention groups will be compared in terms of psychosocial functioning, symptom severity, rates of remission from CHR, and rates of transition to psychosis.
Additionally, factors like patient treatment preference, family emotional climate, and sociodemographic factors will be explored as potential moderators of treatment outcomes.
Qualitative interviews will be conducted with participants and clinicians to inform dissemination efforts.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Psychosis typically emerges in late adolescence or early adulthood, which is a vital stage in social and cognitive development, and can therefore have a profoundly adverse impact on an individual's long-term functioning.
The onset of psychosis is preceded by a clinical high risk (CHR) phase characterized by attenuated psychotic symptoms and functional decline.
CHR programs have enormous potential to reduce the long-term severity of the illness, and the suffering and cost associated with it.
Youth at CHR also typically have environmental and individual-level barriers to accessing and engaging in services, including stigma, a dearth of trained providers, clinic location and transportation issues, suspiciousness, and a tendency to socially isolate.
Reducing some of these barriers via telehealth interventions may improve treatment accessibility and engagement, thereby improving clinical outcomes.
There is a substantial need to evaluate different CHR interventions to determine which are most effective.
There is also a significant need to systematically investigate remote delivery methods as a way of increasing access to critical services for CHR.
The research team have established Group and Family-Based Cognitive Behavioral Therapy (GF-CBT) program in order to facilitate psychosocial recovery, decrease symptoms, and prevent or delay transition to psychosis in youth at CHR. GF-CBT is grounded in sociocultural ecological systems theory, psychosocial resilience models, and research on information processing in delusions.
GF-CBT has been implemented as part of SAMHSA funded CHR services in New York, Missouri, and Delaware.
The research team have also established Family-Based CBT (F-CBT), in which youth and families learn CBT skills as a family unit, rather than in groups.
The research team have adapted GF-CBT, F-CBT and individual CBT for telehealth delivery (GF-CBT-TH, F-CBT-TH and I-CBT-TH).
This study will investigate the feasibility of implementing these telehealth interventions in the context of routine CHR services, evaluate the impact of the interventions on engaging target mechanisms hypothesized to underlie their effects, and conduct a preliminary evaluation of their comparative efficacy.
Subjects between the ages of 14 and 25 who meet CHR criteria on the SIPS (n=72) and their families will be randomly assigned to receive GF-CBT-TH, F-CBT-TH or I-CBT-TH for a period of 15 weeks.
Data will be collected at baseline, post-treatment, and 3-month follow-up.
Feasibility will be measured by recruitment rate, attendance, and retention.
The following intervention targets will be assessed: cognitive biases, social connectedness, family emotional climate, and family members' proficiency in CBT skills.
The three groups will be compared across the following domains: psychosocial functioning, symptom severity, rates of remission from CHR, and rates of transition to psychosis.
The research team will also explore whether patient treatment preference, family emotional climate and sociodemographic factors differentially moderate treatment outcomes.
Qualitative interviews will be conducted with patients, families, and clinicians to inform dissemination and make adaptations to the implementation manuals.
Study Type
Interventional
Enrollment (Estimated)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yulia Landa, PsyD, MS
- Phone Number: 212-585-4658
- Email: yulia.landa@mssm.edu
Study Contact Backup
- Name: Rachel Jespersen, LMSW
- Phone Number: 212-585-4641
- Email: rachel.jespersen@mssm.edu
Study Locations
-
-
New York
-
New York, New York, United States, 10029
- Recruiting
- Icahn School of Medicine at Mount Sinai
-
Contact:
- Rachel Jespersen, LMSW
- Phone Number: 212-585-4641
- Email: rachel.jespersen@mssm.edu
-
Contact:
- Yulia Landa, PsyD,MS
- Phone Number: 212-585-4658
- Email: yulia.landa@mssm.edu
-
Principal Investigator:
- Yulia Landa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion criteria:
- Age 14-25
- Ability to participate in assessments and treatment in English
- Meets criteria for psychosis-risk on SIPS
- Stable on medications; no changes within 1 month prior to enrollment
- Identification of one "family member" with >4 hours/week contact who is willing to participate ("Family member" can be any blood relative, spouse, significant other, or close friend whom the subject identifies as a consistent and important person in their life).
Exclusion criteria:
- Intellectual disability (IQ<70)
- Medical condition known to cause psychosis
- Moderate or severe substance use disorder and active use within the past 30 days.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group and Family-Based Cognitive Behavioral Therapy (GF-CBT-TH)
GF-CBT via telehealth is an intervention consisting of three parts: 15 group sessions for young people, 15 individual sessions for young people, and 15 group sessions for families.
The group sessions for young people and families focus on teaching CBT skills.
The goal is to enhance reasoning, decision-making, and positive beliefs while reducing cognitive biases, distress, and isolation.
The individual sessions personalize the CBT skills learned in the group, focusing on tailoring skills to personal goals.
Family members also participate in group sessions to learn the same CBT skills and how to prompt and support their young family members in using these skills.
All sessions are conducted via Telehealth
|
CBT skills group is designed to boost peer support, reduce isolation, normalize psychotic-like experiences to lessen distress, reduce cognitive biases, facilitate positive beliefs, and enhance reasoning and decision-making.
CBT skills group uses "CBT to Prevent Paranoia" manual to teach individuals to make adaptive appraisals of their experiences (e.g.
voices and other cognitive intrusions) to prevent the perception of such events as threatening.
CBT skills learned in group are personalized in individual sessions focused on: a) facilitating learning of CBT skills; b) tailoring CBT skills to personal goals; c) facilitating successful interaction with peers in the group; and d) providing academic and vocational support.
Youth may opt to invite family members to join individual sessions as needed.
Family members are taught the same CBT skills that are taught to CHR youth to facilitate use of CBT skills at home.
Family members also learn how to prompt CHR youth to use CBT skills through effective communication, such as empathic listening and encouraging alternative explanations.
CBT skills group for family members uses a combination of didactic learning (skills are described in "CBT Skills for Families" manual and demonstrated via video examples) and practice (skills are role-played).
Youth attend one group session and one individual session per week, and family members attend one group session per week.
|
|
Experimental: Family-Based Cognitive Behavioral Therapy (F-CBT-TH)
F-CBT via telehealth consists of two parts: 15 family sessions and 15 individual sessions for young people.
The family sessions focus on teaching CBT skills to a family units.
The individual sessions with youth personalize the CBT skills learned in the family sessions, focusing on tailoring skills to personal goals.
All sessions are conducted via Telehealth.
|
CBT skills learned in group are personalized in individual sessions focused on: a) facilitating learning of CBT skills; b) tailoring CBT skills to personal goals; c) facilitating successful interaction with peers in the group; and d) providing academic and vocational support.
Youth may opt to invite family members to join individual sessions as needed.
Family members are taught the same CBT skills that are taught to CHR youth to facilitate use of CBT skills at home.
Family members also learn how to prompt CHR youth to use CBT skills through effective communication, such as empathic listening and encouraging alternative explanations.
CBT skills group for family members uses a combination of didactic learning (skills are described in "CBT Skills for Families" manual and demonstrated via video examples) and practice (skills are role-played).
Youth attend one group session and one individual session per week, and family members attend one group session per week.
|
|
Active Comparator: Individual Cognitive Behavioral Therapy (I-CBT-TH)
I-CBT-TH via telehealth consists of two components: 15 CBT Skill Learning sessions and 15 follow-up session that personalizes the learned skills.
All sessions are conducted via Telehealth.
|
CBT skills learned in group are personalized in individual sessions focused on: a) facilitating learning of CBT skills; b) tailoring CBT skills to personal goals; c) facilitating successful interaction with peers in the group; and d) providing academic and vocational support.
Youth may opt to invite family members to join individual sessions as needed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Global Functioning: Role (GFR) Scale
Time Frame: Up to week 28
|
The Global Functioning: Role (GFR) scale, clinician administered scales, derived from the GAF format.
The GFR scale anchor points refer to performance in school, work, or as a homemaker, depending on their primary role.
The GFS scale assesses quantity and quality of peer relationships, level of peer conflict, age appropriate intimate relationships, and involvement with family members.
Ratings on a 10-point scale (1= Extreme Role Dysfunction to 10 = Superior Role Functioning) with higher scores representing better role functioning.
|
Up to week 28
|
|
Global Functioning: Social (GFS) Scale
Time Frame: Up to week 28
|
The Global Functioning: Social (GFS) scales, clinician administered scales, derived from the GAF format.
The GFS scale assesses quantity and quality of peer relationships, level of peer conflict, age appropriate intimate relationships, and involvement with family members.
The GFS scale scores range from 1 to 10 with higher scores representing better social functioning.
|
Up to week 28
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Structured Interview for Psychosis Risk Syndromes (SIPS)
Time Frame: Up to week 28
|
Symptom severity will be measured by SIPS, which consists of five positive-symptoms subscales (Unusual thought content/ delusional ideas, Suspiciousness/persecutory ideas, Grandiosity, Perceptual abnormalities/hallucinations, and Disorganized communication), as well as subscales for negative, disorganization, and general symptoms.
SIPS will also be used to compare the three arms on rates of remission from CHR and number of transitions to psychosis.
There are 19 items on the SIPS.
Each item is scored 0-6.
There are 5 positive symptom items (range=0-30), 6 negative symptom items (range=0-36), 4 disorganization symptom items (range=0-24), and 4 general symptom items (range=0-24).
The range of scores is 0-114.
A lower score represents more favorable outcomes.
|
Up to week 28
|
|
Peters' Delusions Inventory (PDI)
Time Frame: Up to week 28
|
The Peters' Delusions Inventory (PDI), a self-report scale measuring the presence of 21 common delusional thoughts and the distress, preoccupation, and conviction associated with each belief.
The Peters Delusional Inventory (PDI) assesses the presence and severity of delusional beliefs.
It is used to measure the intensity and conviction of delusions in individuals experiencing psychosis or related conditions.
The PDI consists of a series of statements that the respondent rates based on their agreement or disagreement.
The PDI includes a total of 21 items, and each item is rated on a 5-point Likert scale ranging from 1 to 5.
There are 3 subscales: Distress, preoccupation and conviction.
Higher scores on the PDI indicate a greater intensity and conviction of delusional beliefs.
The scale ranges from 0 to 336, with 0 indicating no endorsement of delusion.
|
Up to week 28
|
|
Davos Assessment of Cognitive Biases
Time Frame: Up to week 28
|
Cognitive biases will be assessed using the Davos Assessment of Cognitive Biases, a self-report scale that measures cognitive biases across the following sub-scales: Jumping to Conclusions Bias, Belief Inflexibility Bias, Attention for Threat Bias, External Attribution Bias, Social Cognition Problems, Subjective Cognitive Problems, and Safety Behaviors.
The scale ranges from 42 to 294, with higher scores indicating higher cognitive biases .
|
Up to week 28
|
|
Social Connectedness Scale Revised
Time Frame: Up to week 28
|
Social connectedness will be assessed using the Social Connectedness Scale Revised, a 20-item self-report scale that measures the degree to which one feels connected to their social environment.
The scale ranges from 20 to 120, with higher scores indicating greater social connectedness.
|
Up to week 28
|
|
Family Attitudes Scale (FAS)
Time Frame: Up to week 28
|
The Family Attitudes Scale (FAS) is a 30-item scale that can be completed by any informant to measure the family emotional climate.
Participating family members will complete the Family Attitudes Scale.
The scale ranges from 0 to 120, with higher scores indicating more negative attitudes.
|
Up to week 28
|
|
Angry Behaviors Scale (ABS)
Time Frame: Up to week 28
|
Youth will complete the Angry Behaviors Scale (ABS), which is comprised of four items from the FAS.
The scale ranges from 0 to 16, with higher scores indicating greater expression of anger.
|
Up to week 28
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Yulia Landa, Icahn School of Medicine at Mount Sinai
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 21, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
July 21, 2023
First Submitted That Met QC Criteria
July 21, 2023
First Posted (Actual)
August 1, 2023
Study Record Updates
Last Update Posted (Actual)
January 20, 2026
Last Update Submitted That Met QC Criteria
January 16, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GCO 21-0328
- R34MH128502 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All of the individual participant data collected during the trial, after deidentification.
IPD Sharing Time Frame
Beginning 3 months and ending 5 years following article publication.
IPD Sharing Access Criteria
Researchers who provide a methodologically sound proposal.
Any purpose.
Specify Other Mechanism Data will be shared via secured file sharing platform
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clinical High Risk for Psychosis (CHR)
-
Monument Therapeutics LimitedNational Institute of Mental Health (NIMH); Foundation for the National Institutes... and other collaboratorsRecruitingClinical High Risk for Psychosis (CHR)United States
-
University of OxfordWellcome Trust; Jazz PharmaceuticalsNot yet recruitingClinical High Risk for Psychosis | Clinical High Risk for Psychosis (CHR) | Clinical High Risk for Developing PsychosisUnited Kingdom, Italy, Greece, Finland, Germany, Netherlands, Austria, Canada, Spain, Switzerland
-
Centre Psychothérapique de NancyRecruitingClinical High Risk for Psychosis (CHR)France
-
Centre for Addiction and Mental HealthNot yet recruitingClinical High Risk for Psychosis (CHR)Canada
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH); Stony Brook Medicine; Columbia University... and other collaboratorsNot yet recruitingClinical High Risk for Psychosis (CHR)
-
Centre Psychothérapique de NancyRecruitingClinical High Risk for Psychosis (CHR)France
-
University of Alabama at BirminghamNot yet recruitingSchizophrenia | Clinical High Risk for Psychosis (CHR)United States
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)Enrolling by invitationFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
Centre Psychothérapique de NancyNot yet recruitingClinical High Risk for Psychosis (CHR)France
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)RecruitingClinical High Risk for Psychosis (CHR)Tunisia
Clinical Trials on CBT Skills Group for CHR Youth
-
Montclair State UniversityChildren's Hospital of Philadelphia; Drexel UniversityRecruitingAnxiety | Autism Spectrum DisorderUnited States
-
University of California, San FranciscoCompletedDepressionUnited States
-
University of MinnesotaNational Institute of Mental Health (NIMH)Completed
-
Baylor College of MedicineAmerican National Red CrossCompletedAnger | Depressive Disorder | PTSD | Depressive Symptoms | Anxiety DisorderUnited States
-
University of California, IrvineUniversity of Maryland, Baltimore CountyActive, not recruitingSuicide | Psychosis | Health Care Utilization | Family MembersUnited States
-
University Grants CommissionCompleted
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)Active, not recruitingPsychotic Disorders | Psychosis | Prodromal Schizophrenia | Prodromal Symptoms | FamilyUnited States, Canada
-
The Royal Ottawa Mental Health CentreEnrolling by invitationParaphilias and Paraphilic DisordersCanada
-
Dr. Orit HamielMaccabi Healthcare Services, Israel; Academic College of Tel Aviv-JaffaCompleted
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States